Introvale Kit
Product Images NDC 70700-208

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Introvale (NDC 70700-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levonorgestrel And Ethinyl Estradiol Tablets, Usp 0.15 mg /0.03 mg (Image 01)

Packaging label for Introvale 0.15 mg/0.03 mg tablets. This human prescription drug kit contains Levonorgestrel and Ethinyl Estradiol tablets, USP. The box holds 3 extended-cycle blister packs, each with 91 tablets. The labeler is Xiromed LLC, with NDC 70700-208. The design features yellow and green accents with clear dosage and product information.*

FDA Label Image

Figure 1: Likelihood Of Developing A Vte (Image 02)

A horizontal bar chart depicting the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC user, COC-User, Pregnancy, and Postpartum (12 weeks only). The chart shows ranges for each group, with the highest range seen in the Postpartum group (40 to 65).*

FDA Label Image

Figure 2: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)

A forest plot chart comparing effect estimates from various studies on combined oral contraceptive (COC) use versus never use, including odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals. The horizontal axis is labeled 'Effect Estimate' with a range from -1.50 to 2.00, and studies are listed with corresponding data points and confidence intervals.*

FDA Label Image

Levonorgestrel Stuctural Formula (Image 04)

Chemical structure diagram of Levonorgestrel, showing its molecular framework, molecular formula C21H28O2, and molecular weight 312.4.*

FDA Label Image

Ethinyl Estradiol Stuctural Formula (Image 05)

Chemical structure of Ethinyl Estradiol showing its molecular formula C20H24O2 and molecular weight 296.4. The structure depicts the steroid core with attached functional groups typical of this synthetic estrogen compound.*

FDA Label Image

Patient Information (Chance of Getting Pregnant Estimate)

A vertical chart illustrating pregnancy rates per 100 women in one year relative to birth control methods. It categorizes methods from 'Implants, Injections, Intrauterine devices, Sterilization' with fewer than 1 pregnancy, to 'Birth control pills, Skin patch, Vaginal ring with hormones' with low pregnancies, followed by 'Condoms, Diaphragm' with moderate pregnancies, 'No sex during fertile days, Spermicide, Withdrawal' with higher pregnancies, and 'No birth control' with 85 or more pregnancies per 100 women.*

FDA Label Image

Instructions For Use Figure A (Image 07)

INTROVALE Levonorgestrel and Ethinyl Estradiol Tablets Kit label panels showing calendar-style tablet arrangement for 13 weeks. Each panel displays weekly rows with days Sunday through Saturday, and circles representing 28 or 35 tablets. The label includes dosage strength USP 0.15 mg/0.03 mg, storage instructions, labeler Xiromed LLC, and manufacturing details from India.*

FDA Label Image

Instructions For Use Figure B (Image 09)

Packaging label of Introvale Levonorgestrel and Ethinyl Estradiol tablets kit showing a 28-tablet blister pack with a weekly layout for days Sunday through Saturday. The strength is 0.15 mg Levonorgestrel and 0.03 mg Ethinyl Estradiol per tablet. Manufactured for Xiromed LLC, Florham Park, NJ, with storage instructions. Made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.